Industry News

Feb 28, 2018
By BioPharm International Editors
PharmaMar has released the results of MI130004, a novel antibody drug conjucate created using a molecule of marine origin.
Feb 23, 2018
By BioPharm International Editors
The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.
Feb 22, 2018
By BioPharm International Editors
The research partnership will focus on advancing regenerative medicine using porcine bioproducts.
Feb 22, 2018
By BioPharm International Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 21, 2018
By BioPharm International Editors
The agency released draft guidance on the format for electronic submissions of NDA and BLA content regarding the planning of bioresearch monitoring inspections.
Feb 20, 2018
By BioPharm International Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 15, 2018
By BioPharm International Editors
FDA Commissioner Scott Gottlieb issued a statement that FDA will be modernizing regulatory programs in order to advance novel treatments.
Feb 15, 2018
By BioPharm International Editors
Researchers at the University of Illinois developed a method to transplant pancreatic islet cells from pigs more easily to treat type I diabetes.
Feb 14, 2018
The Trump budget boosts funding for FDA but squeezes resources for NIH and healthcare.
Feb 12, 2018
By BioPharm International Editors
A new report states that more research and clinical development must be done in the treatment of pain and addiction.
native1_300x100
lorem ipsum